-
Loading metrics
Open Access
Peer-reviewed
Research Article
Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study
-
Caitrin W. McDonough,
Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America
⨯ -
Nancy K. Gillis,
Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America
⨯ -
Abdullah Alsultan,
Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America
⨯ -
Shin-Wen Chang,
Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America
⨯ -
Marina Kawaguchi-Suzuki,
Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America
⨯ -
Jason E. Lang,
Affiliation Division of Pulmonary and Sleep Medicine and Center for Pharmacogenomics and Translational Research, Nemours Children’s Hospital, Orlando, Florida, United States of America
⨯ -
Mohamed Hossam A. Shahin,
Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America
⨯ -
Thomas W. Buford,
Affiliation Department of Aging and Geriatric Research, University of Florida, College of Medicine, Gainesville, Florida, United States of America
⨯ -
Nihal M. El Rouby,
Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America
⨯ -
Ana C.C. Sá,
Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America
⨯ -
Taimour Y. Langaee,
Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America
⨯ -
John G. Gums,
Affiliations Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America, Department of Community Health and Family Medicine, University of Florida, College of Medicine, Gainesville, Florida, United States of America
⨯ -
Arlene B. Chapman,
Affiliation Renal Division, Department of Medicine, Emory University, Atlanta, Georgia, United States of America
⨯ -
Rhonda M. Cooper-DeHoff,
Affiliations Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America, Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, Florida, United States of America
⨯ -
Stephen T. Turner,
Affiliation Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, United States of America
⨯ -
Yan Gong,
Affiliation Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America
⨯ - [ ... ],
-
Julie A. Johnson
* E-mail: Johnson@cop.ufl.edu
Affiliations Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, College of Pharmacy, Gainesville, Florida, United States of America, Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, Florida, United States of America
⨯ - [ view all ]
- [ view less ]
Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study
- Caitrin W. McDonough,
- Nancy K. Gillis,
- Abdullah Alsultan,
- Shin-Wen Chang,
- Marina Kawaguchi-Suzuki,
- Jason E. Lang,
- Mohamed Hossam A. Shahin,
- Thomas W. Buford,
- Nihal M. El Rouby,
- Ana C.C. Sá
- Published: October 7, 2013
- https://doi.org/10.1371/journal.pone.0076984